US Bancorp DE cut its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 31.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 38,299 shares of the health services provider’s stock after selling 17,715 shares during the quarter. US Bancorp DE’s holdings in Teladoc Health were worth $992,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Forum Financial Management LP boosted its position in shares of Teladoc Health by 14.4% during the first quarter. Forum Financial Management LP now owns 3,094 shares of the health services provider’s stock worth $223,000 after buying an additional 390 shares during the period. Amalgamated Bank boosted its holdings in Teladoc Health by 1.3% during the 4th quarter. Amalgamated Bank now owns 30,399 shares of the health services provider’s stock valued at $719,000 after acquiring an additional 392 shares during the period. Treasurer of the State of North Carolina increased its stake in Teladoc Health by 0.7% during the first quarter. Treasurer of the State of North Carolina now owns 70,207 shares of the health services provider’s stock worth $1,818,000 after purchasing an additional 500 shares during the period. Canada Pension Plan Investment Board boosted its stake in shares of Teladoc Health by 21.6% in the first quarter. Canada Pension Plan Investment Board now owns 2,900 shares of the health services provider’s stock valued at $209,000 after purchasing an additional 515 shares during the period. Finally, Mariner LLC lifted its holdings in Teladoc Health by 2.7% during the 4th quarter. Mariner LLC now owns 19,877 shares of the health services provider’s stock worth $470,000 after buying an additional 525 shares in the last quarter. 81.81% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the company. 888 reissued a “maintains” rating on shares of Teladoc Health in a research report on Friday, April 28th. 58.com restated a “maintains” rating on shares of Teladoc Health in a report on Thursday, April 27th. StockNews.com started coverage on shares of Teladoc Health in a research note on Thursday, August 17th. They set a “sell” rating for the company. Barclays raised their price target on Teladoc Health from $28.00 to $29.00 in a research note on Thursday, April 27th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Teladoc Health from $27.00 to $29.00 in a report on Friday, April 28th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $31.20.
Check Out Our Latest Research Report on TDOC
Insider Buying and Selling at Teladoc Health
In other news, CEO Jason N. Gorevic sold 10,000 shares of Teladoc Health stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $30.03, for a total value of $300,300.00. Following the sale, the chief executive officer now owns 596,246 shares of the company’s stock, valued at $17,905,267.38. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CEO Jason N. Gorevic sold 10,000 shares of Teladoc Health stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $30.03, for a total value of $300,300.00. Following the sale, the chief executive officer now directly owns 596,246 shares in the company, valued at $17,905,267.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Claus Torp Jensen sold 6,547 shares of Teladoc Health stock in a transaction that occurred on Wednesday, July 26th. The shares were sold at an average price of $29.00, for a total transaction of $189,863.00. Following the sale, the insider now owns 13,096 shares of the company’s stock, valued at $379,784. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,639 shares of company stock valued at $587,119. 1.63% of the stock is owned by company insiders.
Teladoc Health Stock Performance
NYSE TDOC opened at $22.84 on Wednesday. The firm has a market cap of $3.77 billion, a P/E ratio of -0.92 and a beta of 1.10. Teladoc Health, Inc. has a 52-week low of $21.60 and a 52-week high of $35.31. The business’s 50-day moving average price is $24.85 and its 200 day moving average price is $25.57. The company has a quick ratio of 3.36, a current ratio of 3.45 and a debt-to-equity ratio of 0.67.
Teladoc Health (NYSE:TDOC – Get Free Report) last announced its earnings results on Tuesday, July 25th. The health services provider reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.04. Teladoc Health had a negative return on equity of 7.32% and a negative net margin of 158.76%. The company had revenue of $652.41 million for the quarter, compared to the consensus estimate of $649.20 million. During the same period last year, the business posted ($0.44) EPS. The company’s revenue was up 10.1% on a year-over-year basis. On average, equities research analysts expect that Teladoc Health, Inc. will post -1.36 earnings per share for the current year.
Teladoc Health Profile
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teladoc Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Teladoc Health wasn’t on the list.
While Teladoc Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Source: marketbeat.com
